Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • China mulls USD...

    China mulls USD 720,000 fine for faking vaccine tests after scandal

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-11-13T09:42:19+05:30  |  Updated On 13 Nov 2018 9:42 AM IST
    China mulls USD 720,000 fine for faking vaccine tests after scandal




    Beijing: Chinese vaccine manufacturers who falsify test results or break other rules could be fined up to USD 720,000 under a new law proposed after a scandal that fulled public fears over domestically made medicine. The law would regulate areas including production, distribution and use of vaccines, according to a draft posted Sunday on the website of China's market regulator.

    The country was earlier this year rocked by a scandal that saw a manufacturer of rabies vaccines fabricating records.

    While authorities say the affected vaccines did not enter the market, the case provoked outrage from consumers fed up with recurring product safety scandals, particularly in pharmaceuticals.

    Under the proposed law, those who flout the rules can be fined up to 5.0 million yuan (USD 720,000) for offences including submitting false test results, not recalling problematic batches and "other serious illegal acts".

    "Those who participate in illegal behaviour, shield or connive with violators, hide the facts through fabrication, or impede investigation will receive severe punishment," the draft said.

    This is the first time a law has explicitly targeted vaccines, which were previously covered by regulations controlling medicine.

    The authorities last month slapped the Changchun Changsheng Biotechnology company with a massive USD 1.3 billion in penalties over the rabies vaccine scandal.

    The firm's chairwoman and 14 other people were arrested in connection with the affair in July while more than a dozen national, provincial and local officials were sacked, including several senior officials from the drug regulatory agency.

    China is regularly hit by scandals involving sub-par or toxic food, drugs and other products, despite repeated promises by the government to address the problem.

    After the latest case came to light, the authorities announced a nationwide inspection of laboratories producing vaccines.

    But many Chinese parents say they no longer have confidence in the medicines administered to their children.

    During the height of the scandal, clinics in Hong Kong saw a run on their vaccine stocks by worried parents from the mainland.

    President Xi Jinping described the vaccine debacle as "vile" and "shocking" in July while Premier Li Keqiang said the latest case had crossed a "line of human ethics".

    In August, India ordered a recall of rabies vaccines made by Changchun Changsheng and complained that it only found out about possible problems through media reports.






    BeijingBiotechnology companyChangchunChangshengchinafaking vaccinefineHong KongLi KeqiangmullsPharmaceuticalsrabies vaccinescandaltestvaccineXi Jinping
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok